Ibruxen 140 mg
Ibrutinib
Ibruxen 140mg is used to treat MCL, CLL/SLL, WM, and MZL in adults by targeting cancer cell growth via kinase inhibition.
- Strengths 140mg
- Form Capsules
- Packaging Size 120 Capsules
- Packaging Type Box
- Manufacturer EVEREST PHARMA PRODUCTS
Description of Ibruxen 140 mg
Ibruxen 140mg Capsule contains Ibrutinib, a targeted kinase inhibitor used in the treatment of various blood cancers. It is prescribed for adults with Mantle Cell Lymphoma (MCL) post at least one prior therapy, Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) including those with 17p deletion, Waldenström’s Macroglobulinemia (WM), and Marginal Zone Lymphoma (MZL) requiring systemic therapy. Ibruxen 140mg works by blocking Bruton’s tyrosine kinase, a protein essential for cancer cell survival and growth. Continued usage is often guided by clinical outcomes and ongoing monitoring. It must be taken exactly as prescribed by your physician.
Ingredients of Ibruxen 140 mg
- Ibrutinib
Usage of Ibruxen 140 mg
- Take orally once daily with a glass of water
- Follow the dosage as directed by your doctor
- Do not crush or chew the capsule
Precautions for Ibruxen 140 mg
- Not recommended during pregnancy or breastfeeding
- Monitor blood counts, liver, and kidney functions regularly
- Report unusual bleeding, bruising, or infections immediately
- Avoid grapefruit or grapefruit juice during treatment
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
